AVOLLA
DEAD

Serial Number

87641245

Owner

Teva Pharmaceuticals USA, Inc.

Filing Date

Oct 11, 2017

Add to watchlist:

No watchlists yet
View on USPTO

AVOLLA Trademark

Serial Number: 87641245

AVOLLA is a trademark filed by Teva Pharmaceuticals USA, Inc. on October 11, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Teva Pharmaceuticals USA, Inc. (585 trademarks)

650 Cathill Road
Sellersville, PA 18960

Entity Type: 03

Trademark Details

Filing Date

October 11, 2017

Registration Date

Not Registered

Published for Opposition

March 20, 2018

Goods & Services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 21, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 21, 2021 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 25, 2020 EXRA
SOU EXTENSION 5 GRANTED
Nov 24, 2020 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 23, 2020 AITU
SOU EXTENSION 5 FILED
Nov 9, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 9, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 7, 2020 EXRA
SOU EXTENSION 4 GRANTED
May 5, 2020 EX4G
SOU EXTENSION 4 FILED
May 5, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
May 5, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 15, 2019 EXRA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 13, 2019 TCCA
SOU EXTENSION 3 GRANTED
Nov 13, 2019 EX3G
SOU EXTENSION 3 FILED
Nov 13, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 13, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 10, 2019 EXRA
SOU EXTENSION 2 GRANTED
May 8, 2019 EX2G
SOU EXTENSION 2 FILED
May 8, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
May 8, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 14, 2018 EXRA
SOU EXTENSION 1 GRANTED
Nov 12, 2018 EX1G
SOU EXTENSION 1 FILED
Nov 12, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 12, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 15, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 20, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 20, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 28, 2018 NONP
ASSIGNED TO LIE
Feb 2, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 19, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 17, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 17, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 11, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jan 11, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jan 11, 2018 CNRT
ASSIGNED TO EXAMINER
Jan 10, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 18, 2017 NWOS
NEW APPLICATION ENTERED
Oct 14, 2017 NWAP